Effectiveness of extract and fraction of robusta coffee beans (Coffea canephora) against streptozotosin-nicotinamide induced blood glucose levels of male white mice
Main Article Content
Abstract
Robusta coffee bean have compounds flavonoids, alkaloids, saponins and tannins. This compound has the benefit of being an antihyperglycemic which plays a role in inhibiting absorption glucose, preventing the formation of AGEs chains, and increasing the activity of antioxidant enzymes. This research aims to determine the effectiveness of the robusta coffee bean fraction which is effective in reducing blood glucose levels in STZ-NA induced mice. Research conducted is experimental research. Using 30 mice aged 2-3 months with a body weight of 18-25 g and grouped into 6 groups, that is group I negative streptozotocin 5.6 mg/kg weight and nicotinamide 15.4 mg/kg weight, group II positive control was given glibenclamide 0.65 mg/kg weight, Group III was given robusta coffee bean extract 400 mg/kg weight Group IV was given the n-hexane fraction of 42 mg/kg weight, group V was given the ethyl acetate fraction of 38 mg/kg weight, group VI was given the water fraction of 216 mg/kg weight. The data has been analyzed and after 21 days of observation it was found that the ethyl acetate fraction and robusta coffee bean extract decreased blood glucose levels the same as the decrease in blood glucose levels in the positive group test.
Article Details
References
American Diabetes Association, ADA standards of diabetes care 2021, vol. 44(Suppl 1). Diabetes Care , 2021.
DiPiro, Pharmacotherapy Handbook 9th edition. McGraw-Hill Education., 2015.
Kemenkes, “Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020,” Pusat Data dan Informasi Kementrian Kesehatan RI , pp. 1–10, 2020.
Firdaus, S. A. Marliyati, and K. Roosita, “Model Tikus Diabetes Yang Diinduksi Sterptozotocin- Sukrosa Untuk Pendekatan Penelitian Diabetes Streptozotocin , Sucrose- Induce Diabetic Male Rats Model for Research,” Jurnal MKMI, vol. 12, no. 1, pp. 29–34, 2016.
A. Ghasemi, S. Khalifi, and S. Jedi, “Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review),” Acta Physiol. Hung., vol. 101, no. 4, pp. 408–420, 2014.
E. I. Wigati, E. Pratiwi, T. Fatwatun, N. Dan, and N. F. Utami, “Uji karakteristik fitokimia dan aktivitas antioksidan biji kopi robusta (coffea canephora pierre) dari bogor, bandung dan garut dengan metode dpph (1,1-diphenyl-2-picrylhydrazyl),” FITOFARMAKA, vol. 8, no. 1, 2018, doi: 10.33751/jf.v8i1.1172.
A. Farah and C. M. Donangelo, “Phenolic compounds in coffee,” Brazilian Journal of Plant Physiology, vol. 18, no. 1, pp. 23–36, Mar. 2006, doi: 10.1590/S1677-04202006000100003.
D. Tousch et al., “Chicoric acid, a new compound able to enhance insulin release and glucose uptake,” Biochem. Biophys. Res. Commun., vol. 377, no. 1, pp. 131–135, Dec. 2008, doi: 10.1016/j.bbrc.2008.09.088.
A. Ghorbani, “Mechanisms of antidiabetic effects of flavonoid rutin,” Biomedicine & Pharmacotherapy, vol. 96, pp. 305–312, Dec. 2017, doi: 10.1016/j.biopha.2017.10.001.
S. V. M. Larantukan, N. L. E. Setiasih, and S. K. Widyastuti, “Pemberian Ekstrak Etanol Kulit Batang Kelor Glukosa Darah Tikus Hiperglikemia,” Indonesia Medicus Veterinus, vol. 3, no. 4, pp. 292–299, 2014.
H. Rasouli, R. Yarani, F. Pociot, and J. Popović-Djordjević, “Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives,” Pharmacol. Res., vol. 155, p. 104723, May 2020, doi: 10.1016/j.phrs.2020.104723.
M. Kumari and J. Shasi, “Tannins: An Antinutrient with Positive Effect to Manage Diabetes,” Res. J. Recent Sci., vol. 1, no. 12, 2012.
Q. Wang, X. Wu, F. Shi, and Y. Liu, “Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice,” Biomedicine & Pharmacotherapy, vol. 109, pp. 744–750, Jan. 2019, doi: 10.1016/j.biopha.2018.09.098.